Skip to content

Virusspeedtest

Active
Private limited companyfounded 20205 yrs activeDennenlei 18, 2900 Schoten, BelgiumKBO/BCE: BE 0757.727.574

The computed 12-month bankruptcy probability of Virusspeedtest is 2.0% (moderate). The 2025 annual accounts show equity of €23k and a net result of €-6k. Equity is shrinking by ~26.4% per year across the filed fiscal years. Its solvency ranks better than 95% of 10345 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
52 / 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0▼-100
Solvency100=
Growth32=
Track record94
Bankruptcy probability, 12 months
2.0% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days acceptable
Liquidity ample (current ratio 10.34; short-term debt: 9.7% and cash: 0.7% of total assets), and 9.7% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 5 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
90.3%
Return on assets
-23.8%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 17-03-2026, 44 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
44 d early
2024
41 d early
2023
35 d early
2022
40 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
22-09-2026 today30-09-2026 close30-04-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€23k▼ 20.8%
2024 · €29k
2022: €73k 2023: €14k 2024: €29k
2022 → 2025
Total assets
€26k▼ 12.5%
2024 · €30k
2022: €99k 2023: €14k 2024: €30k
2022 → 2025
Net result
€-6k
2024 · €16k
2022: €67k 2023: €-59k 2024: €16k
2022 → 2025
Working capital
€23k▼ 20.8%
2024 · €29k
2022: €72k 2023: €13k 2024: €29k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line2022202320242025Trend
Equity€73k-€14k▼ 81.4%€29k▲ 118%€23k▼ 20.8%
Operating result€90k-€-58k€16k€-6k
Net result€67k-€-59k€16k€-6k
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-100k€-50k€0€50k€100kOperating result 2022: €90k€90kNet result 2022: €67k€67kOperating result 2023: €-58k€-58kNet result 2023: €-59k€-59kOperating result 2024: €16k€16kNet result 2024: €16k€16kOperating result 2025: €-6k€-6kNet result 2025: €-6k€-6k2022202320242025
The operating result turns negative in 2025: a loss of €6k after €16k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €26k
Equity €23k▼ 20.8%
Debt €3k▲ 4,941%
The debt ratio rises from 0.2% to 9.7%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€-6k
2024 · €17k
Cash flow
€-6k
2024 · €16k
Solvency
90.3%
2024 · 99.8%
Current ratio
10.34
Quick ratio
10.34
Debt / equity
0.11
2024 · 0.00
ROE
-26.3%
2024 · 54.2%
ROA
-23.8%
2024 · 54.1%
Interest coverage
-31.34
2024 · 59.57
Debt
€3k
2024 · €50
Debt ≤ 1 year
€3k
2024 · €50
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€30k€26k
Fixed assets21/28€0-
Tangible fixed assets22/27€0-
Furniture and vehicles24€0-
Current assets29/58€30k€26k
Amounts receivable within one year40/41€27k€25k
Trade receivables40€9k€8k
Other amounts receivable41€17k€17k
Cash at bank and in hand54/58€3k€192
Deferred charges and accrued income490/1€218€163
Equity and liabilities
Total equity and liabilities10/49€30k€26k
Equity10/15€29k€23k
Contributions10/11€6k€6k=
Reserves13€23k€17k
Distributable reserves133€23k€17k
Amounts payable17/49€50€3k
Amounts payable within one year42/48€50€3k
Trade debts44€50€0
Suppliers440/4€50€0
Other amounts payable47/48-€3k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€369€0
Other operating charges640/8€951€854
Gross operating margin9900€18k€-5k
Operating profit (loss)9901€16k€-6k
Financial income75/76B€0-
Recurring financial income75€0-
Financial charges65/66B€279€190
Recurring financial charges65€279€190
Profit (loss) for the period before taxes9903€16k€-6k
Profit (loss) for the period9904€16k€-6k
Profit (loss) for the period to be appropriated9905€16k€-6k
Appropriation of the result
Profit (loss) to be appropriated9906€16k€-6k
Transfer from equity791/2€0€6k
Transfer to equity691/2€16k€0
To other reserves6921€16k€0

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 30-04-2027
2026
17-03
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
20-03
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
30-09
Financial Back to profitnet €16k
Net result €16k after one loss-making year.
30-09
Financial Liquidity times 28current ratio 595.70
Current ratio from 21.04 to 595.70; short-term debt falls from €656 to €50.
26-03
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
30-09
Financial Weakest financial yearnet €-59k ▼189%
Net result drops to €-59k, the lowest in the series; recovery starts the following year.
30-09
Financial Liquidity times 6current ratio 21.04
Current ratio from 3.69 to 21.04; short-term debt falls from €27k to €656.
21-03
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schoten · 1 establishment unit since 2020
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Dennenlei 182900 Schoten
Ground area
2,729 m²
Building footprint
193 m²
Volume, LiDAR
1,202 m³
Parcel 11040D0153/00G010, Flanders · tallest building 9.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Virusspeedtest
Dennenlei 18, 2900 SchotenWholesale of pharmaceutical and medical goods
since 20202.309.544.660
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11040D0153/00G010 Flanders 2,729 m² 1 · 192 m² 9.9 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2023 to 2025 · 3 entries · 25,000 EUR awarded
Year Entries awardedpaid
2025 2 0 EUR0 EUR
2023 1 25,000 EUR0 EUR
Schemes
Kmo-groeisubsidie: steun voor groeitrajecten bij kmo's (stopgezet)
3 entries · 25,000 EUR · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 1,070 companies in sector 47741 we hold annual accounts for 644. 336 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded02-11-2020
Fiscal year end30-09
Activities, NACEBEL
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.